back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-02-16 10:18 Tx date 2026-02-11 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-699,999.30
-333,333 vol $2.10 each |
||
| Filed 2026-02-12 04:07 Tx date 2026-02-11 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-699,999.30
-333,333 vol $2.10 each |
||
| Filed 2026-02-13 17:01 Tx date 2026-02-11 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$-699,999.30
-333,333 vol $2.10 each |
926,892 | |
| Filed 2026-02-12 04:07 Tx date 2026-02-11 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-699,999.30
-333,333 vol $2.10 each |
1,260,225 | |
| Filed 2026-01-16 17:40 Tx date 2026-01-01 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+468,750 vol |
1,593,558 | |
| Filed 2026-01-16 17:37 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+375,000 vol |
375,000 | |
| Filed 2026-01-16 17:35 Tx date 2025-02-10 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+749,808 vol |
1,124,808 | |
| Filed 2026-01-16 17:32 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-16 17:32 Tx date 2025-01-06 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-375,000 vol |
1,124,808 | |
| Filed 2026-01-16 17:26 Tx date 2026-01-01 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-375,000 vol |
0 | |
| Filed 2026-01-16 17:20 Tx date 2024-11-22 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+375,000 vol |
1,499,808 | |
| Filed 2026-01-16 17:16 Tx date 2025-02-10 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-749,808 vol |
375,000 | |
| Filed 2026-01-16 17:12 Tx date 2023-12-06 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+375,000 vol |
1,124,808 | |
| Filed 2026-01-16 17:08 Tx date 2023-02-10 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+749,808 vol |
749,808 | |
| Filed 2026-01-16 16:57 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-22 11:29 Tx date 2023-02-13 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+1,500 vol $0.90 each |
24,258,982 | |
| Filed 2023-02-17 16:28 Tx date 2023-02-13 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,758
+11,100 vol $0.88 each |
24,257,482 | |
| Filed 2023-02-17 16:28 Tx date 2023-02-13 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,477
+9,600 vol $0.88 each |
24,246,382 | |
| Filed 2023-02-17 16:26 Tx date 2023-02-13 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-218,131,038 vol |
24,236,782 | |
| Filed 2023-01-26 11:46 Tx date 2023-01-25 |
$LOVE
Cannara Biotech Inc. |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+200,000 vol $0.105 each |
242,367,820 | |
| Filed 2021-04-14 15:01 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
231,832,194 | ||
| Filed 2020-08-20 18:10 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-09 12:17 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-20 18:10 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
231,761,250 | ||
| Filed 2019-01-09 12:17 Tx date 2018-12-31 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-20 15:16 Tx date 2020-02-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$743,524
+8,161,626 vol $0.0911 each |
242,167,820 | |
| Filed 2019-08-15 16:42 Tx date 2019-08-15 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,185
+27,000 vol $0.155 each |
234,006,194 | |
| Filed 2019-08-15 16:41 Tx date 2019-08-15 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,729
+98,000 vol $0.1503 each |
233,979,194 | |
| Filed 2019-08-09 15:31 Tx date 2019-08-09 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,202
+422,000 vol $0.1474 each |
233,881,194 | |
| Filed 2019-08-08 11:21 Tx date 2019-08-07 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,299
+345,000 vol $0.1371 each |
233,459,194 | |
| Filed 2019-03-14 Tx date 2019-03-13 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$238,323
+1,282,000 vol $0.1859 each |
233,114,194 | |
| Filed 2019-01-09 Tx date 2018-12-31 |
$
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
6,000,001 | ||
| Filed 2019-01-09 Tx date 2018-12-31 |
$
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Krivorot, Zohar
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Javaa Private Equity Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
231,832,194 |